Carcinoma, Hepatocellular: all 3,249 studies
Page 1 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver CancerRecruitingNCT07884877Phase 2
- SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular CarcinomaNot yet recruitingNCT07882056Phase 2
- Multimodal Liquid-Biopsy Omics Biomarkers of Treatment Response in Breast CancerNot yet recruitingNCT07880106
- Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT07878689Phase 1/2
- Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image RegistrationNot yet recruitingNCT07877220Not applicable
- Prevention of Bile Leakage After Liver Resection in ChildrenRecruitingNCT07867522Not applicable
- Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular CarcinomaNot yet recruitingNCT07866612Not applicable
- STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular CarcinomaRecruitingNCT07863258
- Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIsNot yet recruitingNCT07861425Phase 1
- A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)RecruitingNCT07850882
- InstaSure™ Non-Invasive Finger-Press Test for Hepatocellular CarcinomaRecruitingNCT07848750
- Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular CarcinomaRecruitingNCT07840092
- Treatment Selection by 3D Bioprinting Liver Model to Prevent Liver Cancer RecurrenceRecruitingNCT07839767
- Multimodalomics-based Construction of Spatiotemporal Characteristics of Dynamic Liver Cancer Microenvironment to Characterize the Clinical Application of Immune Mechanisms in Liver CancerRecruitingNCT07838415
- Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular CancerNot yet recruitingNCT07836712Phase 2
- Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular CarcinomaNot yet recruitingNCT07836530Phase 3
- TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602)Not yet recruitingNCT07836309
- Irreversible Electroporation Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT07832006Phase 2
- Lenvatinib Plus Tislelizumab With or Without Gefitinib for Advanced Liver CancerNot yet recruitingNCT07829926Phase 2
- PEARL Trial: Partial TACE Enhancing Anti-tumor Response With Lenvatinib in Unresectable HCCNot yet recruitingNCT07827807Phase 2
- A Study Evaluating a New Radiation Treatment Workflow (NGDS)RecruitingNCT07824583Not applicable
- JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Treatment for Advanced Liver CancerNot yet recruitingNCT07823348Phase 3
- Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepatocellular Carcinoma and Comparative Analysis With SurgicalNot yet recruitingNCT07815054
- Real-world Insight Into Systemic Therapies for HCC: Single-center StudyRecruitingNCT07814014
- ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced HepatocellularNot yet recruitingNCT07813572Phase 3
- Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune FunctionRecruitingNCT07811687
- ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortRecruitingNCT07808164
- Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Treatment of Potentially Resectable Intermediate-Stage HCCRecruitingNCT07801287Phase 2
- GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular CarcinomaRecruitingNCT07795437Not applicable
- Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular CarcinomaRecruitingNCT07793695Phase 2
- Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCCNot yet recruitingNCT07786792
- Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular CarcinomaRecruitingNCT07782632
- Different Acupoint Stimulation for Postoperative Gastrointestinal Dysfunction in Primary Liver Cancer PatientsNot yet recruitingNCT07781176Not applicable
- HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis BNot yet recruitingNCT07780357
- Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor ThrombusRecruitingNCT07776080Phase 2
- Atezolizumab, Bevacizumab, and Tocilizumab in Advanced Hepatocellular CarcinomaNot yet recruitingNCT07774247Phase 2
- Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CTNot yet recruitingNCT07768085Not applicable
- Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)Not yet recruitingNCT07764835
- Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaNot yet recruitingNCT07761286Phase 1/2
- 68Ga-SorB PET/CT Imaging in Patients With Solid TumorsRecruitingNCT07760012Not applicable
- Development and Dissemination of Exercise Prescription and Intervention for Cancer PopulationsRecruitingNCT07751783Not applicable
- SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular CarcinomaNot yet recruitingNCT07749859Phase 2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular CarcinomaNot yet recruitingNCT07748481
- Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular CarcinomaNot yet recruitingNCT07734857
- Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNot yet recruitingNCT07732686
- AI-Guided Surveillance and Curative Salvage of Recurrence After Hepatocellular Carcinoma Resection or AblationNot yet recruitingNCT07732504Not applicable
- Dapagliflozin Add-on in Unresectable HCC With Metabolic SyndromeNot yet recruitingNCT07729592Phase 2
- CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver FailureRecruitingNCT07727759
- The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical StudyNot yet recruitingNCT07724951
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.RecruitingNCT07717437
- Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver CancerNot yet recruitingNCT07716345
- Breath Research Narrow Validation for Gastrointestinal Cancer DetectionRecruitingNCT07714538
- Phase Ib/II Multicenter Randomized Control Study of Peri-operative Treatment With Combination of CTLA-4, PD-1 Antibodies and Bevacizumab in Resectable HCC (Prophet)Not yet recruitingNCT07714317Phase 1/2
- Safety and Feasibility of CIK Cell Therapy in HCC After Tumor ResectionNot yet recruitingNCT07709299Early Phase 1
- Application of Super-Resolution Ultrasound (SRUS) in Liver TumorNot yet recruitingNCT07707661
- FAPI PET Imaging - An Exploratory StudyNot yet recruitingNCT07705074Phase 1/2
- San Raffaele Registry on Liver CancerRecruitingNCT07704489
- Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver CancerNot yet recruitingNCT07704216
- Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing HepatectomyNot yet recruitingNCT07704203
- Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular CarcinomaEnrolling by invitationNCT07703735
- A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular CarcinomaNot yet recruitingNCT07691762Phase 3
- Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat SyndromeNot yet recruitingNCT07691645Phase 2
- Patients With Hepatocellular Carcinoma (HCC)Not yet recruitingNCT07690683Not applicable
- Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular CarcinomaRecruitingNCT07689175Phase 2
- A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular CarcinomaNot yet recruitingNCT07687914Phase 2
- AI-Driven Tumor Response Evaluation for Solid TumorsNot yet recruitingNCT07685548
- Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial NitroglycerinNot yet recruitingNCT07682454Phase 2
- Risk Stratification and Proactive Nursing Intervention for Acute Kidney Injury Following Interventional Therapy in Patients With Liver CancerNot yet recruitingNCT07681817Not applicable
- First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)RecruitingNCT07679061
- GPC3-Targeted PET/CT in Hepatocellular CarcinomaRecruitingNCT07677774Not applicable
- HCC Risk and Monitoring in Patients With Type 2 DiabetesNot yet recruitingNCT07675187Not applicable
- A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.Not yet recruitingNCT07669727
- SBRT Plus QL1706 as Second-Line Therapy for Hepatocellular CarcinomaNot yet recruitingNCT07668570Phase 4
- Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource SettingsNot yet recruitingNCT07667608
- A Study Evaluating the Safety and Efficacy of Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres to Bridge or Downstage Patients With Hepatocellular Carcinoma (HCC) to Liver Transplant or Resection and Elicit Pathologic Necrosis.Not yet recruitingNCT07663487Phase 2
- TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCCRecruitingNCT07658833
- NK521 in the Treatment of Advanced Solid TumorsNot yet recruitingNCT07657416Early Phase 1
- Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular CarcinomaNot yet recruitingNCT07657273Phase 2
- CHARM Hepatocellular Carcinoma MEA StudyRecruitingNCT07650773
- Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsNot yet recruitingNCT07645742Not applicable
- PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative HepatectomyNot yet recruitingNCT07644208Phase 2
- 68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid TumorsNot yet recruitingNCT07639801Not applicable
- Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCCRecruitingNCT07639138Phase 2
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsRecruitingNCT07636785Phase 1/2
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceRecruitingNCT07636148
- Liver Transplant for Hepatocellular CarcinomaNot yet recruitingNCT07629193
- A Study of Standard Of Care Versus Radio Ablation in Early Stage HCCRecruitingNCT07628751Not applicable
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerRecruitingNCT07627191Early Phase 1
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- Improving the Use of Immunotherapy to Treat Liver CancerRecruitingNCT07623265Not applicable
- Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored StudyEnrolling by invitationNCT07620574Phase 3
- A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence FactorsNot yet recruitingNCT07618546Not applicable
- OE MRI to Predict Treatment Response After TACE in HCC PatientsEnrolling by invitationNCT07617038Not applicable
- Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular CarcinomaRecruitingNCT07610551
- Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing PancreatectomyNot yet recruitingNCT07608458Not applicable
- MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.RecruitingNCT07607769
- Evaluation of Tissue and Circulating microRNA Profiles in Patients With Hepatocellular Carcinoma Subjected to Thermal AblationRecruitingNCT07601464
- A Comparative Study on the Diagnostic Efficacy of Ultrasound Contrast LI-RADS Grading and the German ESCULAP Standards for the Diagnosis of Recurrent Hepatic Mass Lesions After Hepatocellular Carcinoma SurgeryNot yet recruitingNCT07600346
- To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid TumorsRecruitingNCT07594964Phase 1